We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Analyzers and Laboratory Information Systems Linked Through Single Workstation

By LabMedica International staff writers
Posted on 14 Oct 2010
Print article
Image: Remisol Advance v 1.4 - data management system for hospital laboratories (photo courtesy Beckman Coulter).
Image: Remisol Advance v 1.4 - data management system for hospital laboratories (photo courtesy Beckman Coulter).
A data management system links analyzers and laboratory information systems (LIS) through a single workstation, providing technicians with a comprehensive real-time view of the clinical laboratory testing lifecycle.

The Remisol Advance system was designed to improve laboratory turnaround times and productivity and reduce medical errors. It manages the laboratory process from the initial test request, through verification and release of results, to the LIS.

The improved user interface features workflow enhancements and better usability. Utilizing the new Wide Area Networking (WAN) and Local Area Networking (LAN) configurations, it simplifies and streamlines workflow, enabling technicians to program and review test requests for all interfaced instruments.

Released by Beckman Coulter (Brea, CA, USA), the Remisol Advance v1.4 improves on existing features of the single-screen view--now providing automated STAT notifications and alerts regarding critical patient results. This minimizes processing delays and speeds up delivery of critical sample results to clinicians.

Autoverification allows tests with normal results to be released to the LIS so laboratory staff can focus on priority patient samples. In the case of critical or life-threatening results, technicians are immediately notified and provided with instructions on the next steps required to eliminate delays and reduce turnaround times.

The new system is capable of managing Beckman Coulter instruments, including automation, chemistry, special chemistry; i class integrated systems, immunoassay, hematology, and hemostasis platforms.

A Comprehensive Service package is available that starts with implementation and offers coverage throughout the lifetime of Remisol Advance.

Related Links:

Beckman Coulter




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.